Safety and effectiveness of switch to bictegravir/emtricitabine/tenofovir alafenamide following dual regimen therapy in people with HIV : Insights from the Icona cohort
2025; Wiley; Linguagem: Inglês
10.1111/hiv.70037
ISSN1468-1293
AutoresAndrea De Vito, Alessandro Tavelli, Alessandro Cozzi‐Lepri, Andrea Giacomelli, Roberto Rossotti, Giacomo Ponta, Nicoletta Bobbio, Alice Ianniello, Antonella Cingolani, Giordano Madeddu, Andrea Antinori, Antonella d’Arminio Monforte,
Tópico(s)HIV-related health complications and treatments
Referência(s)